Rutu Ruparel

Rutu Ruparel is the founder and chief executive of Oncera Health, a digital cancer survivorship platform for the years after treatment ends.

She started Oncera after watching her own family navigate life after cancer. What struck her was not the treatment itself but what came afterwards: the appointments that had structured everything simply stopped, the side effects did not, and there was almost no guidance for the stretch that followed. That gap, between the end of active treatment and the rest of someone's life, is the problem Oncera was built to work on.

Rutu studies molecular biology at The University of Texas at Austin, and the scientific grounding shows in how the product is put together. Oncera is organized around the seven domains of survivorship rather than a single symptom tracker, and its content is built on published research and validated instruments rather than on general wellness advice. She is equally firm about the boundary: Oncera is educational and non-diagnostic, it does not diagnose, treat, or predict recurrence, and it is not a substitute for anyone's care team.

She speaks regularly on cancer science and survivorship. Her TEDx talk, "Biomarkers: The Future of Cancer Care", was delivered at TEDx Leander High School Youth in 2025 and covered the role of biomarkers in cancer detection, precision medicine, and treatment, drawing on her own family's experience. She has also presented "Epigenetics After Cancer, How Everyday Habits Support Your Body's Recovery" as one of four expert speakers at a National Cancer Survivor Day survivorship fair, walking survivors through what the evidence does and does not support about sleep, movement, nutrition, and alcohol after treatment.

Her work on Oncera has been recognized by the Kendra Scott Women's Entrepreneurial Leadership Institute, where she was one of five student founders selected to pitch at the Changemakers Summit Spark Founders Pitch Showcase and received a five thousand dollar award, and by the Harkey Institute for Entrepreneurial Studies, whose 2026 McCombs Entrepreneur Summer Fellowship funded her to build the company full time.

She leads product direction and the editorial standards the platform is held to, and she works directly with survivors, clinicians, and survivorship programs on what the months after treatment actually require.